BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23360884)

  • 1. Gut microbiota and metabolic disorders: How prebiotic can work?
    Delzenne NM; Neyrinck AM; Cani PD
    Br J Nutr; 2013 Jan; 109 Suppl 2():S81-5. PubMed ID: 23360884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.
    Parnell JA; Raman M; Rioux KP; Reimer RA
    Liver Int; 2012 May; 32(5):701-11. PubMed ID: 22221818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between obesity and the gut microbiota: relevance in nutrition.
    Delzenne NM; Cani PD
    Annu Rev Nutr; 2011 Aug; 31():15-31. PubMed ID: 21568707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.
    Neyrinck AM; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):722-8. PubMed ID: 20823777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.
    Delzenne NM; Neyrinck AM; Cani PD
    Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21995448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, metabolic syndrome, and microbiota: multiple interactions.
    Tilg H
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the gut in visceral fat inflammation and metabolic disorders.
    Lam YY; Mitchell AJ; Holmes AJ; Denyer GS; Gummesson A; Caterson ID; Hunt NH; Storlien LH
    Obesity (Silver Spring); 2011 Nov; 19(11):2113-20. PubMed ID: 21881620
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and obesity.
    Krznarić Z; Vranešić Bender D; Kunović A; Kekez D; Stimac D
    Dig Dis; 2012; 30(2):196-200. PubMed ID: 22722438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing future prebiotic fiber to target metabolic syndrome.
    Jakobsdottir G; Nyman M; Fåk F
    Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.